Vineet Laboratories Limited (VINEETLAB) Share Price & AI Investment Analysis

Vineet Laboratories Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API), intermediates, and fine chemicals primarily in India. The company offers intermediates of Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, Piroctone Olanine, and other API intermediates. It also provides fine chemicals and reagents, such as isopropyl-beta-d-thiogalactopyranoside, n-butyl lithium, 4-nitrophenyl phosphate disodium salt, 5-bromo-4-chloro-3-indolyl-beta-d-galactopyranoside, 5-acetyl thiophene-2-carboxilic acid, 4-chlorobutyryl chlorid. Track Vineet Laboratories Limited's live NSE:VINEETLAB share price ₹35.05 (+0.69%), market cap ₹₹67Cr, P/E 35.0. MarketRipple's AI analysis covers the investment thesis, ripple-chain impact, and Basic Materials sector outlook for VINEETLAB — real-time NSE India stock intelligence.